VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

SOHO 2020 | Innovative CAR designs

Renier J. Brentjens • 10 Sep 2020
SOHO 2020
General CAR-T
Immuno-Oncology Perspectives Treatment

Renier J. Brentjens, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses novel CAR designs aimed to improve the efficacy of CAR T-cell recipients, including the development of armored CAR T-cells able to further penetrate malignancies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc)

More from Renier J. Brentjens

3:16
Challenges in CAR T-cell therapy
Renier J. Brentjens • 10 Sep 2020

Related Videos

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
1:26
Rapid CAR-T manufacturing and challenges in this space
Nina Worel • 9 Feb 2023
1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
2:34
Generating iSPC-derived MSCs with the Cymerus™ Platform
Ross Macdonald • 19 Apr 2022
The content of VJRegenMed is intended for healthcare professionals